期刊
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
卷 1851, 期 1, 页码 40-50出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbalip.2014.09.021
关键词
Dihydroceramide; Lipotoxicity; DEGS1; Desaturase
资金
- Medical Research Council Programme [FP7-ETHERPATHS (KBBE-2007-2A-222639-2)]
- British Heart Foundation (BHF) [PG/08/003/24286]
- MRC [G0600717, MC_UU_12012/5, MC_UU_12012/2, G0802051] Funding Source: UKRI
- British Heart Foundation [RG/12/13/29853] Funding Source: researchfish
- Medical Research Council [G0802051, G0600717, MC_UU_12012/5, MC_UU_12012/2, MC_UU_12012/5/B, G0600717B] Funding Source: researchfish
The pathogenic relevance of sphingolipid metabolism is increasingly being recognised. Here we elaborate on a new player within the sphingolipid field: the degs1 enzyme, a recently discovered enzyme that catalyses the final step in the de novo biosynthesis of ceramides controlling the step from dihydroceramides to ceramides. Here, we describe its function and dysregulation by factors such as oxidative stress, hypoxia and inflammation and provide evidence indicating that dihydroceramides constitute a biologically active molecule from the sphingolipid family with certain differential characteristics with respect to its delta-4 unsaturated counterparts, the ceramides. Finally we present pathophysiological scenarios characterised by specific increases in dihydroceramide that challenge the concept that all ceramides species are the same. This article is part of a Special Issue entitled Linking transcription to physiology in lipodomics. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据